Department of Urology, Tokyo Women's Medical University, Tokyo, Japan.
Int J Urol. 2013 Nov;20(11):1072-7. doi: 10.1111/iju.12123. Epub 2013 Feb 20.
To investigate the impact of histological subtypes on the survival of patients presenting with renal cell carcinoma extending into the inferior vena cava.
From January 1985 until October 2011, 68 patients with renal cell carcinoma extending into the inferior vena cava underwent radical nephrectomy and inferior vena cava thrombectomy at Tokyo Women's Medical University, Tokyo, Japan. Their clinical and pathological parameters were reviewed from the medical charts.
The median follow up was 19 months (range 0.1-144 months). The tumor thrombus level was I in four patients (6%), II in 38 patients (56%), III in 12 patients (18%) and IV in 14 patients (20%). Papillary histological subtype was found in seven patients (10%), and clear cell in 61 patients (90%). Patients with a papillary subtype had a significantly worse survival outcome than the patients with the clear cell subtype (median survival time 9.0 vs 36.1 months, P < 0.001). Multivariate analysis also showed that the papillary subtype was the only independent prognostic factor for unfavorable cancer-specific survival (P = 0.03). When the patients presented with metastases to lymph nodes or distant metastases, the median survival of the patients with a papillary subtype was extremely short, at just 5.2 months compared with those with a clear cell subtype (24.0 months, P = 0.001).
Patients with renal cell carcinoma extending into the inferior vena cava with a papillary subtype show a considerably shorter survival compared with those with a clear cell subtype. The papillary renal cell carcinoma extending into the inferior vena cava patient might be an inappropriate candidate for extensive surgery when metastases to nodes or distant organs are found.
探讨组织学亚型对肾细胞癌侵犯下腔静脉患者生存的影响。
1985 年 1 月至 2011 年 10 月,68 例肾细胞癌侵犯下腔静脉患者在日本东京女子医科大学行根治性肾切除术和下腔静脉取栓术。从病历中回顾了他们的临床和病理参数。
中位随访时间为 19 个月(0.1-144 个月)。肿瘤栓子水平为Ⅰ级 4 例(6%),Ⅱ级 38 例(56%),Ⅲ级 12 例(18%),Ⅳ级 14 例(20%)。7 例(10%)为乳头状组织学亚型,61 例(90%)为透明细胞型。乳头状亚型患者的生存结果明显差于透明细胞型患者(中位生存时间 9.0 与 36.1 个月,P<0.001)。多因素分析也表明,乳头状亚型是影响癌症特异性生存的唯一独立预后因素(P=0.03)。当患者出现淋巴结转移或远处转移时,乳头状亚型患者的中位生存时间极短,仅为 5.2 个月,而透明细胞型患者为 24.0 个月(P=0.001)。
侵犯下腔静脉的肾细胞癌患者中,具有乳头状亚型的患者与具有透明细胞亚型的患者相比,生存时间明显缩短。当发现淋巴结或远处器官转移时,具有乳头状肾细胞癌侵犯下腔静脉的患者可能不适合广泛手术。